glp 1 agonists vs sglt2 inhibitors GLP-1 Receptor and in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Yumlish 🍝 on X: "SGLT2

Lipid effects of glucagon-like peptide 1 receptor analogs Amanda J

In vitro, 5-Amino-1MQ reduced 1-methylnicotinamide and altered NAD+ and S-adenosylmethionine in adipocytes

Apart from GLP-1 therapies reducing glucose levels (HbA1c) they also offer additional benefits which will influence the prescriber in finding the correct drug for a specific patient outcome

Similar results were observed in healthy older adults, where a 12-week HIIT+CIT intervention led to greater reductions in BMI and android fat mass, alongside larger improvements in gait speed, compared with HIIT plus placebo

Sun M, Chen Z (2024) Unveiling the complex role of exosomes in Alzheimers disease

1 Some have cited concern over confounding variables including the fact that patients with diabetes are at an increased risk of acute pancreatitis regardless of treatment choice